✦ LIBER ✦

Study protocol: safety correction of high dose antipsychotic polypharmacy in Japan

✍ Scribed by Sukegawa, Tsuruhei; Inagaki, Ataru; Yamanouchi, Yoshio; Inada, Toshiya; Yoshio, Takashi; Yoshimura, Reiji; Iwata, Nakao

Book ID: 125399164
Publisher: BioMed Central
Year: 2014
Tongue: English
Weight: 165 KB
Volume: 14
Category: Article
ISSN: 1471-244X
DOI: 10.1186/1471-244X-14-103

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

(415) Sickle cell crisis: safety of a hi

(415) Sickle cell crisis: safety of a high-dose opioid protocol in the emergency department

✍ Tanabe, P.; Paice, J.; Schmelzer, A.; Buckley, B.; Martinovich, Z. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 94 KB

High dose safety and pharmacokinetic stu

High dose safety and pharmacokinetic study of ISIS 2302 in Crohn’s disease

✍ Charles F Barish; John Goff; Douglas Dalke; Michael Gaspari; Joseph Tami; Lea Se 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 27 KB

Safety of high doses of low molecular we

Safety of high doses of low molecular weight heparin (Fragmin) in acute myocardial infarction. A dose - finding study

✍ Anders Nesvold; Frederic Kontny; Ulrich Abildgaard; Jon Dale 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 643 KB

Safety of high doses of low molecular we

Safety of high doses of low molecular weight heparin (Fragmin) in acute myocardial infarction. A dose - finding study

✍ Anders Nesvold; Frederic Kontny; Ulrich Abildgaard; Jon Dale 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 516 KB

Safety of olanzapine at doses higher tha

Safety of olanzapine at doses higher than 20 mg/day versus typical antipsychotics in the treatment of schizophrenic in-patients (EUROPA study)

✍ J. Gascón; A. Ciudad; E. Álvarez; J. Bobes; F. Cañas; J.L. Carrasco; J. Gibert; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 139 KB

Safety, tolerability, and feasibility of

Safety, tolerability, and feasibility of high-dose naltrexone in alcohol dependence: an open-label study

✍ Gihyun Yoon; Suck Won Kim; Paul Thuras; Joseph Westermeyer 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

Objective Prior trials testing standard-dose naltrexone (50 mg/day) have generated mixed results in the treatment of alcohol dependence. The purpose of this study was to evaluate the short-term safety, tolerability, and feasibility of high-dose naltrexone (150 mg/day) for treating alcohol-dependent